Recurrent urinary tract infections in kidney transplant patients with polycystic kidneys
Authors:
Marcel Čellár 1; Martina Konko Ová 1; Eva Lacková 1; Terézia Hrubá 2; Peter Galajda 3; Ivana Dedinská
Authors‘ workplace:
II. interná klinika, Slovenská zdravotnícka univerzita, Nefrologicko‑transplantačné oddelenie, Fakultná nemocnica s poliklinikou F. D. Roosevelta, Banská Bystrica
1; Oddelenie rádiológie, Fakultná nemocnica s poliklinikou F. D. Roosevelta, Banská Bystrica
2; I. interná klinika, Univerzitná nemocnica Martin a Jesseniova lekárska fakulta Univerzity Komenského
3; Transplantačné centrum a I. interná klinika, Univerzitná nemocnica Martin a Jesseniova lekárska fakulta Univerzity Komenského
4
Published in:
Vnitř Lék 2022; 68(E-4): 4-9
Category:
Original Contributions
Overview
Introduction: Kidney transplantation is now a routine method used to treat end-stage renal disease. About 10 % of kidney transplant patients are patients with autosomal dominant polycystic kidney disease (ADPKD). After successful kidney transplantation, recurrent urinary tract infections also occur in initially asymptomatic patients.
Material and methods: The group included 320 patients after kidney transplantation. We compared patients with ADPKD versus patients without ADPKD in terms of the presence of recurrent urinary tract infections.
The results: The incidence of recurrent urinary tract infections (rIMCs) was 18% in patients without ADPKD and 48% in patients without ADPKD. Nephrectomy after kidney transplantation due to recurrent urinary tract infections eliminated this infectious complication (in 86% of patients).
Conclusion: Kidney transplant patients with ADPKD have a significantly higher incidence of recurrent urinary tract infections. Removal of polycystic kidneys is a suitable solution if the infection persists.
Keywords:
kidneys – Transplantation – recurrent urinary tract infection – polycystic kidneys – ADPKD
Sources
1. Kaballo MA, Canney M, O‘Kelly P et al. A comparative analysis of survival of patients on dialysis and after kidney transplantation. Clin Kidney J 2018; 11(3): 389-393.
2. Oxford handbook of nephrology and hypertension. 2nd ed. Oxford: Oxford University Press (2014) s. 336, ISBN 978-0-19-965161-0.
3. Chebib FT, Torres VE. Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2016. Am J Kidney Dis 2016; 67(5): 792-810.
4. Teplan V et al. Praktická nefrologie, Praha: Grada Publishing 2006, ISBN 80-247-1122-2, 496 s.
5. Stuart FP, Abecassis MM, Kaufman DB. Vademecum Organ Transplantation 2nd Edition, Georgetown: Landes Bioscience 2003, ISBN 1-57059-675-1, 810 s.
6. Viklický O, Janoušek L, Baláž P. Transplantace ledviny v klinické praxi, Praha: Grada Publishing 2008, ISBN 978-80-247-2455-3, 384 s.
7. Basu G. Infections After Kidney Transplantation: The Bug BEAR Of Kidney Transplantation in Tropics. The Open Urology & Nephrology Journal 2015; 8:76-87
8. Breza J, Žilinská Z et al. Transplantácia obličky, Ľubotice: Cofin, a. s. 2020, ISBN 978-80-973466-1-4, 289 s.
9. Mitra S, Alangaden GJ. Reccurent Urinary Tract Infections in Kidney Transplant Recipients. Curr Infect Dis Rep 2011; 13: 579-587.
10. Schiescher J. Reccurent UTIs After Renal Transplant. 2010, Dostupné na: http://www. renalandurologynews.com/recurrent‑utis‑after‑renal‑transplants/ article/180801/#
11. Spithoven E, Kramer A, Meijer E et al. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival‑an analysis of data from the ERA‑EDTA Registry. Nephrol Dial Transplant 2014; 29: 15-25.
12. Britt NS, Hagopian JC, Brennan DC et al. Effect of reccurent urinary tract infection on graft and patient outcomes after kidney transplantation. Nephrology Dialysis Transplantation 2017; 32, (10): 1758–1766.
13. Feehally J, Floege J, Tonelli M. Comprehensive Clinical Nephrology Sixth Edition, Elsevier 2018, ISBN 978-0-323-47909-7, 1360 s.
14. Rozanski J, Kozlowska I, Myslak M et al. Pretransplant nephrectomy in patient with autosomal dominat polycystic kidney disease. Transplant proc 2005; 37 (2): 666-668.
15. Chapman AB, Devuyst O, Eckardt KU. Autosomal – dominant polycystic kidney disease (ADPKD): executive sumary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Published online 2015 Mar 18. doi: 10.1038/ki.2015.59, Dostupné na : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913350/
16. Teplan V et al. Praktická nefrologie, Praha: Grada Publishing 2006, ISBN 80-247-1122-2, 496 s.
17. Torres VE, Chapman AB, Devuyst O et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 2012; 367: 2255-2266.
18. Torres VE, Chapman AB, Devuyst O et al. Multicentric, open label, extension trial to evaluate the long‑term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 trial. Nephrol Dial Transplant 2017; 32: 1262.
19. Torres VE, Chapman AB, Devuyst O et al. Tolvaptan in later‑stage autosomal dominant polycystic kidney disease. N Engl J Med 2017; 377: 1930-1943.
20. Veroux M, Zerbo D, Basile G et al. Simultaneous Native Nephrectomy and Kidney Transplantation in Patients With Autosomal Dominant Polycystic Kidney Disease. June 2016, Dostupné na WWW: https://doi.org/10.1371/journal.pone.0155481
21. Kirkman MA, Dellen D, Mehra S et al. Native nephrectomy for autosomal dominant polycystic disease: before or after kidney transplantation. December 2010, Dostupné na WWW: https://doi.org/10.1111/j.1464-410X.2010.09938.x
22. Dedinská I, Laca L, Miklušica J et al. Diabetes mellitus after transplantation. Annals of transplantation research 2017; 1(1): 1005.
23. Nowacka MP, Safranow K, Rózański, J et al. Autosomal Dominant Polycystic Kidney Disease Is Not a Risk For Post‑transplant Diabetes Mellitus. Matched‑pair Design Multicenred Study. Archives of medical research 2008; 39(3): 312-319.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2022 Issue E-4
Most read in this issue
- Acquired von Willebrand syndrome (AvWS)
- Recurrent urinary tract infections in kidney transplant patients with polycystic kidneys
- The position and importance of pharmacovigilance in the Czech Republic and in the world
- Pacient s jaterní cirhózou na interním oddělení – intervence případného abúzu alkoholu